Sarpogrelate treatment reduces restenosis after coronary stenting
Sarpogrelate treatment reduces restenosis after coronary stenting
About this item
Full title
Author / Creator
Publisher
United States: Mosby, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Mosby, Inc
Subjects
More information
Scope and Contents
Contents
Background Sarpogrelate, a serotonin blocker, has been reported to inhibit the serotonin-induced proliferation of rat aortic smooth muscle cells. The aim of this study was to investigate whether sarpogrelate reduces restenosis after coronary stenting as a result of prevention of intimal hyperplasia.
Methods We examined 79 patients with stable an...
Alternative Titles
Full title
Sarpogrelate treatment reduces restenosis after coronary stenting
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_73127644
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73127644
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1067/mhj.2003.176
